Literature DB >> 24813825

Improved long-term memory via enhancing cGMP-PKG signaling requires cAMP-PKA signaling.

Eva Bollen1, Daniela Puzzo2, Kris Rutten1, Lucia Privitera2, Jochen De Vry1, Tim Vanmierlo1, Gunter Kenis1, Agostino Palmeri2, Rudi D'Hooge3, Detlef Balschun3, Harry M W Steinbusch1, Arjan Blokland4, Jos Prickaerts1.   

Abstract

Memory consolidation is defined by the stabilization of a memory trace after acquisition, and consists of numerous molecular cascades that mediate synaptic plasticity. Commonly, a distinction is made between an early and a late consolidation phase, in which early refers to the first hours in which labile synaptic changes occur, whereas late consolidation relates to stable and long-lasting synaptic changes induced by de novo protein synthesis. How these phases are linked at a molecular level is not yet clear. Here we studied the interaction of the cyclic nucleotide-mediated pathways during the different phases of memory consolidation in rodents. In addition, the same pathways were studied in a model of neuronal plasticity, long-term potentiation (LTP). We demonstrated that cGMP/protein kinase G (PKG) signaling mediates early memory consolidation as well as early-phase LTP, whereas cAMP/protein kinase A (PKA) signaling mediates late consolidation and late-phase-like LTP. In addition, we show for the first time that early-phase cGMP/PKG signaling requires late-phase cAMP/PKA-signaling in both LTP and long-term memory formation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24813825      PMCID: PMC4207334          DOI: 10.1038/npp.2014.106

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  42 in total

1.  Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus.

Authors:  Y F Lu; E R Kandel; R D Hawkins
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging.

Authors:  Sheeja Navakkode; Sreedharan Sajikumar; Julietta Uta Frey
Journal:  J Neurosci       Date:  2004-09-01       Impact factor: 6.167

3.  A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

Authors:  A Ennaceur; J Delacour
Journal:  Behav Brain Res       Date:  1988-11-01       Impact factor: 3.332

4.  cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation.

Authors:  Jos Prickaerts; Jan de Vente; Wiel Honig; Harry W M Steinbusch; Arjan Blokland
Journal:  Eur J Pharmacol       Date:  2002-02-01       Impact factor: 4.432

5.  Presynaptic BDNF required for a presynaptic but not postsynaptic component of LTP at hippocampal CA1-CA3 synapses.

Authors:  Stanislav S Zakharenko; Susan L Patterson; Ioannis Dragatsis; Scott O Zeitlin; Steven A Siegelbaum; Eric R Kandel; Alexei Morozov
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

6.  Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat.

Authors:  J Prickaerts; W C G van Staveren; A Sik; M Markerink-van Ittersum; U Niewöhner; F J van der Staay; A Blokland; J de Vente
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

7.  Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus.

Authors:  Yun-Fei Lu; Robert D Hawkins
Journal:  J Neurophysiol       Date:  2002-09       Impact factor: 2.714

Review 8.  Phosphodiesterase type 5 inhibition improves early memory consolidation of object information.

Authors:  Jos Prickaerts; Ayhan Sik; Wilma C G van Staveren; Guido Koopmans; Harry W M Steinbusch; Franz Josef van der Staay; Jan de Vente; Arjan Blokland
Journal:  Neurochem Int       Date:  2004-11       Impact factor: 3.921

9.  Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences.

Authors:  W Krause; G Kühne
Journal:  Xenobiotica       Date:  1988-05       Impact factor: 1.908

10.  Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory.

Authors:  Agostino Palmeri; Lucia Privitera; Salvatore Giunta; Carla Loreto; Daniela Puzzo
Journal:  Behav Brain Res       Date:  2012-11-19       Impact factor: 3.332

View more
  25 in total

1.  The neuroprotective and antidepressant-like effects of Hcyb1, a novel selective PDE2 inhibitor.

Authors:  Li Liu; Jing Zheng; Xian-Feng Huang; Xia Zhu; Shu-Ming Ding; Heng-Ming Ke; James M O'Donnell; Han-Ting Zhang; Guo-Qiang Song; Ying Xu
Journal:  CNS Neurosci Ther       Date:  2018-04-27       Impact factor: 5.243

2.  The phosphodiesterase 5 inhibitor, KJH-1002, reverses a mouse model of amnesia by activating a cGMP/cAMP response element binding protein pathway and decreasing oxidative damage.

Authors:  Lijun Zhang; Jae Hong Seo; Huan Li; Ghilsoo Nam; Hyun Ok Yang
Journal:  Br J Pharmacol       Date:  2018-07-10       Impact factor: 8.739

3.  Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory.

Authors:  Agostino Palmeri; Roberta Ricciarelli; Walter Gulisano; Daniela Rivera; Claudia Rebosio; Elisa Calcagno; Maria Rosaria Tropea; Silvia Conti; Utpal Das; Subhojit Roy; Maria Adelaide Pronzato; Ottavio Arancio; Ernesto Fedele; Daniela Puzzo
Journal:  J Neurosci       Date:  2017-06-16       Impact factor: 6.167

4.  Neuromodulatory Action of Picomolar Extracellular Aβ42 Oligomers on Presynaptic and Postsynaptic Mechanisms Underlying Synaptic Function and Memory.

Authors:  Walter Gulisano; Marcello Melone; Cristian Ripoli; Maria Rosaria Tropea; Domenica D Li Puma; Salvatore Giunta; Sara Cocco; Daniele Marcotulli; Nicola Origlia; Agostino Palmeri; Ottavio Arancio; Fiorenzo Conti; Claudio Grassi; Daniela Puzzo
Journal:  J Neurosci       Date:  2019-05-24       Impact factor: 6.167

5.  Selective phosphodiesterase-2A inhibitor alleviates radicular inflammation and mechanical allodynia in non-compressive lumbar disc herniation rats.

Authors:  Jun-Nan Wang; Xue-Jun Zhao; Zhi-Hua Liu; Xu-Li Zhao; Tao Sun; Zhi-Jian Fu
Journal:  Eur Spine J       Date:  2017-03-10       Impact factor: 3.134

6.  Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress.

Authors:  Ying Xu; Jianchun Pan; Jiao Sun; Lianshu Ding; Lina Ruan; Miranda Reed; Xuefeng Yu; Jonathan Klabnik; Dan Lin; Jianxin Li; Ling Chen; Chong Zhang; Hanting Zhang; James M O'Donnell
Journal:  Neurobiol Aging       Date:  2014-08-30       Impact factor: 4.673

Review 7.  Phosphodiesterase 4D: an enzyme to remember.

Authors:  Roberta Ricciarelli; Ernesto Fedele
Journal:  Br J Pharmacol       Date:  2015-09-22       Impact factor: 8.739

8.  Soluble Guanylate Cyclase Stimulators and Activators.

Authors:  Peter Sandner; Daniel P Zimmer; G Todd Milne; Markus Follmann; Adrian Hobbs; Johannes-Peter Stasch
Journal:  Handb Exp Pharmacol       Date:  2021

9.  Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice.

Authors:  Lindsay M Lueptow; Chang-Guo Zhan; James M O'Donnell
Journal:  Psychopharmacology (Berl)       Date:  2015-11-02       Impact factor: 4.530

Review 10.  Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond.

Authors:  George S Baillie; Gonzalo S Tejeda; Michy P Kelly
Journal:  Nat Rev Drug Discov       Date:  2019-08-06       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.